Gupta Medicose (India) Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 22 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 1.15 Cr
- Revenue Growth 49.10%
- Profit Growth 226.35%
- Ebitda 44.01%
- Net Worth 8.24%
- Total Assets 7.53%
About Gupta Medicose (India)
Gupta Medicose (India) Private Limited (GMIPL) is a Private Limited Indian Non-Government Company incorporated in India on 17 October 2002 and has a history of 22 years and four months. Its registered office is in Gurugram, Haryana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company has closed loans amounting to ₹1.15 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Suman Gupta and Virender Gupta serve as directors at the Company.
Company Details
- Location
Gurugram, Haryana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51397HR2002PTC034980
- Company No.
034980
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Oct 2002
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Gupta Medicose (India)?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suman Gupta  | Director | 17-Oct-2002 | Current |
| Virender Gupta | Director | 17-Oct-2002 | Current |
Financial Performance of Gupta Medicose (India).
Gupta Medicose (India) Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 49.1% increase. The company also saw a substantial improvement in profitability, with a 226.35% increase in profit. The company's net worth moved up by a moderate rise of 8.24%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gupta Medicose (India)?
In 2021, Gupta Medicose (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0
₹11.50 M
Charges Breakdown by Lending Institutions
- Others : 1.15 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Mar 2016 | Others | ₹4.00 M | Satisfied |
| 02 Dec 2002 | Others | ₹7.50 M | Satisfied |
How Many Employees Work at Gupta Medicose (India)?
Unlock and access historical data on people associated with Gupta Medicose (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gupta Medicose (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gupta Medicose (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
